Log In
BCIQ
Print this Print this
 

Optivar, azelastine solution

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
DescriptionAntihistamine ophthalmic solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat allergic conjunctivitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today